PHARMAGREEN BIOTECH INC. — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/0a59fd83-f883-4b7d-811e-0469651f6e26/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-1.1M | 2021-10-01 – 2022-09-30 | evidence 0001477932-23-000296 |
| FY 2021 | $-744.1k | 2020-10-01 – 2021-09-30 | evidence 0001477932-21-009538 |
| FY 2020 | $-485.8k | 2019-10-01 – 2020-09-30 | evidence 0001273511-21-000011 |
| FY 2019 | $-642.2k | 2018-10-01 – 2019-09-30 | evidence 0001273511-21-000011 |
| FY 2018 | $-748.7k | 2017-10-01 – 2018-09-30 | evidence 0001273511-19-000126 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).